Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Geriatric Comanagement in Older Patients Undergoing Surgery for Gastrointestinal Cancer: A Retrospective, Before-and-After Study.
Giannotti C, Massobrio A, Carmisciano L, Signori A, Napolitano A, Pertile D, Soriero D, Muzyka M, Tagliafico L, Casabella A, Cea M, Caffa I, Ballestrero A, Murialdo R, Laudisio A, Incalzi RA, Scabini S, Monacelli F, Nencioni A. Giannotti C, et al. Among authors: nencioni a. J Am Med Dir Assoc. 2022 Nov;23(11):1868.e9-1868.e16. doi: 10.1016/j.jamda.2022.03.020. Epub 2022 May 13. J Am Med Dir Assoc. 2022. PMID: 35569527 Clinical Trial.
Proteasome inhibitors: antitumor effects and beyond.
Nencioni A, Grünebach F, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Leukemia. 2007 Jan;21(1):30-6. doi: 10.1038/sj.leu.2404444. Epub 2006 Nov 9. Leukemia. 2007. PMID: 17096016 Review.
Immunotherapy with dendritic cells for cancer.
Ballestrero A, Boy D, Moran E, Cirmena G, Brossart P, Nencioni A. Ballestrero A, et al. Among authors: nencioni a. Adv Drug Deliv Rev. 2008 Jan 14;60(2):173-83. doi: 10.1016/j.addr.2007.08.026. Epub 2007 Oct 5. Adv Drug Deliv Rev. 2008. PMID: 17977615 Review.
The use of dendritic cells in cancer immunotherapy.
Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P. Nencioni A, et al. Crit Rev Oncol Hematol. 2008 Mar;65(3):191-9. doi: 10.1016/j.critrevonc.2007.10.002. Epub 2007 Dec 4. Crit Rev Oncol Hematol. 2008. PMID: 18055210 Review.
Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.
Bruzzone S, Fruscione F, Morando S, Ferrando T, Poggi A, Garuti A, D'Urso A, Selmo M, Benvenuto F, Cea M, Zoppoli G, Moran E, Soncini D, Ballestrero A, Sordat B, Patrone F, Mostoslavsky R, Uccelli A, Nencioni A. Bruzzone S, et al. Among authors: nencioni a. PLoS One. 2009 Nov 19;4(11):e7897. doi: 10.1371/journal.pone.0007897. PLoS One. 2009. PMID: 19936064 Free PMC article.
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients.
Ballestrero A, Cirmena G, Dominietto A, Garuti A, Rocco I, Cea M, Moran E, Nencioni A, Miglino M, Raiola AM, Bacigalupo A, Patrone F. Ballestrero A, et al. Among authors: nencioni a. Int J Lab Hematol. 2010 Aug 1;32(4):387-91. doi: 10.1111/j.1751-553X.2009.01198.x. Epub 2009 Nov 30. Int J Lab Hematol. 2010. PMID: 19968720
Ras-induced resistance to lapatinib is overcome by MEK inhibition.
Zoppoli G, Moran E, Soncini D, Cea M, Garuti A, Rocco I, Cirmena G, Grillo V, Bagnasco L, Icardi G, Ansaldi F, Parodi S, Patrone F, Ballestrero A, Nencioni A. Zoppoli G, et al. Among authors: nencioni a. Curr Cancer Drug Targets. 2010 Mar;10(2):168-75. doi: 10.2174/156800910791054211. Curr Cancer Drug Targets. 2010. PMID: 20088787
219 results